Trifecta Capital Advisors, LLC

Position in JNJ — Johnson & Johnson

CIK 1962615 NORTHBROOK, IL

Position in JNJ

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$974,228

+$9,424 QoQ

Shares Held

3,836

-2.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#3,042

of 4,676 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Trifecta Capital Advisors, LLC holds $49,578,365 across 11 Drug Manufacturers - General names. JNJ ranks #4 (2.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	25,670	$30,789,370
2	ABBV	AbbVie Inc.	41,305	$10,393,990
3	AMGN	Amgen Inc	16,502	$5,975,704
4	JNJ	Johnson & Johnson This page	3,836	$974,228
5	MRK	Merck & Co., Inc.	5,740	$737,590
6	GILD	Gilead Sciences, Inc.	3,202	$404,540
7	NVO	Novo Nordisk A S	4,016	$192,527
8	PFE	Pfizer Inc	4,277	$102,990

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$974,228	3,836	-2.8%	Shares	Sole	2026-08-03
2026-03-31	$964,804	3,947	0.0%	Shares	Sole	2026-05-01
2025-12-31	$816,831	3,947	-4.8%	Shares	Sole	2026-01-30
2025-09-30	$769,122	4,148	+3.2%	Shares	Sole	2025-11-03
2025-06-30	$614,207	4,021	+64.5%	Shares	Sole	2025-07-23
2025-03-31	$405,478	2,445	-1.5%	Shares	Sole	2025-04-21
2024-12-31	$359,091	2,483	0.0%	Shares	Sole	2025-02-04
2024-09-30	$402,394	2,483	-4.8%	Shares	Sole	2024-10-16
2024-06-30	$381,039	2,607	-86.4%	Shares	Sole	2024-08-07
2024-03-31	$3,042,151	19,231	-2.5%	Shares	Sole	2024-04-16
2023-12-31	$3,092,950	19,733	-1.4%	Shares	Sole	2024-01-25
2023-09-30	$3,117,336	20,015	+0.8%	Shares	Sole	2023-11-01
2023-06-30	$3,285,240	19,848	-2.6%	Shares	Sole	2023-08-14
2023-03-31	$3,158,280	20,376	+4.8%	Shares	Sole	2023-05-09
2022-12-31	$3,434,959	19,445	—	Shares	Sole	2023-01-18
No filing history on record for this holder in this stock.